Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447882 · ClinicalTrials.gov registry record · NA
Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task
A NA study of Motor Activity, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT07447882: Active NA study of Motor Activity, sponsored by Indiana University.
NCT07447882 is a NA study of Motor Activity that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 52 participants, below the 71-participant average among 6 other Motor Activity trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07447882, a NA study of Motor Activity, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Virtual reality as a gaming method is being used more regularly due to its immersive environments and total body playability. A few studies have used VR paired with brain stimulation as a clinical treatment for PTSD (van't Wout-Frank et al. 2024), as well as for regaining movement and cognitive abilities following stroke (Cheng et al. 2024; Lima et al. 2024). While a clinical use for VR and brain stimulation is the ultimate goal, there have still been no basic science investigations studying the efficacy of pairing the two. This investigation will be the first in exploring the connection between VR and brain stimulation as it relates to behavioral improvements (learning the game quicker) and eventually we will begin to study the exact cortical changes that facilitate the accelerated learning. The game "Beat Saber" was chosen because it requires the subjects to move their arm in a large 3-Dimensional space and gives a performance metric after each trial to measure improvement
Primary Outcome
Beat Saber is a virtual reality (VR) rhythm game where players use motion controllers to slice, with virtual sabers, colored blocks that fly toward them in time with electronic music. The total number of good hits during the post-assessment game performance will be tallied and compared to the total number of good hits from the pre-assessment game performance.
Conditions Studied
Interventions
- DEVICE tDCS
Study Locations (1)
Indiana
- National Institute for Fitness and Sport - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2025-04-23 |
| Est. Completion | 2026-04-23 |
| Phase | NA |
What the registry record for NCT07447882 still lists
NCT07447882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 71-participant average among 6 other Motor Activity trials with a reported enrollment target (27% lower).
The record links to 1 condition, with Motor Activity appearing as the primary indexed condition, and to 1 intervention - of which tDCS is the first listed.
NCT07447882 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07447882 about?
NCT07447882 is a clinical study titled "Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task". Virtual reality as a gaming method is being used more regularly due to its immersive environments and total body playability. A few studies have used VR paired with brain stimulation as a clinical treatment for PTSD (van't Wout-Frank et al. 2024), as well as for regaining movement and cognitive abil...
What is the current status of trial NCT07447882?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2025-04-23. Estimated completion is 2026-04-23.
What conditions does trial NCT07447882 study?
This clinical trial studies the following conditions: Motor Activity.
What interventions are being tested in trial NCT07447882?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT07447882?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07447882 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Motor Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults
RECRUITING · NA
-
Implementation of IVS3 for Upper Limb Motor Recovery
RECRUITING · NA
-
Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task
RECRUITING · NA
-
Fit Physicians: Use of Activity Monitors and Activity Integration Program in First Year Medical Students
COMPLETED · NA
-
Noninvasive VNS to Facilitate Excitability in Motor Cortex
COMPLETED · NA
-
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI